A type of hemipelvic prosthesis
By integrating a drug reservoir and a drug release port into the acetabular cup of the hemipelvic prosthesis, the problem of low concentration of anti-infective drugs in systemic infusion was solved, achieving high local drug release, improving the anti-infective effect and reducing the toxicity risk of systemic medication.
Patent Information
- Application Number
- CN202521655099.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2025-08-05
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2035-08-05
AI Technical Summary
Postoperative infection control after hemipelvic implant surgery mainly involves the infusion of systemic anti-infective drugs. However, the drug concentration at the site of infection is low, which is particularly ineffective for patients with weakened immune systems.
Design an acetabular cup for a hemipelvic prosthesis, comprising a cup body and an inner liner. The cup body has a drug reservoir and a drug release port. Before surgery, an anti-infective drug is pre-loaded and sealed with an absorbable occluder. After surgery, the occluder is gradually absorbed, and the drug release port automatically opens, allowing the drug to act directly on the infected site and increase the local drug concentration.
By locally releasing anti-infective drugs, the drug concentration at the site of infection can be significantly increased, reducing the hepatotoxicity and nephrotoxicity of systemic administration. This approach is suitable for patients with weakened immune systems and avoids increasing surgical trauma and foreign body reactions to implants.
Smart Images

Figure CN224975050U_ABST
Abstract
Description
Technical Field
[0001] This utility model relates to the field of medical device technology, and in particular to a hemipelvic prosthesis. Background Technology
[0002] A hemipelvic prosthesis is an implant used to replace one side of the pelvis, primarily in surgeries where the hemipelvic structure is severely damaged due to tumors, severe trauma, or bone infection, making preservation or reconstruction impossible. The acetabular cup is one of the core load-bearing components of the hemipelvic prosthesis; its function is to replace the damaged acetabulum, forming an articular surface with the femoral head to enable hip joint movement. Hemipelvic prosthesis surgery involves a large implant and significant trauma, making the surgical site prone to postoperative infection. Current techniques often involve postoperative intravenous administration of systemic anti-infective drugs to prevent or treat infection. However, patients undergoing hemipelvic prosthesis surgery are often cancer patients or those with severe trauma, whose immune systems are weakened, resulting in low concentrations of systemic anti-infective drugs at the infection site. Utility Model Content
[0003] The technical problem to be solved by this invention is that the anti-infection after hemipelvic prosthesis surgery is mainly achieved by infusion of systemic anti-infective drugs, and the concentration of systemic anti-infective drugs at the site of infection is low.
[0004] To address the aforementioned technical problems, the purpose of this utility model is to provide a hemipelvic prosthesis, including an acetabular cup. The acetabular cup comprises a cup body, an inner liner, and an absorbable sealing member. The cup body has an inner liner mounting cavity, and at least a portion of the inner liner is disposed within the inner liner mounting cavity. The cup body includes a cup wall for surrounding the inner liner mounting cavity. The cup wall has a drug storage cavity and a drug release hole. One end of the drug release hole communicates with the drug storage cavity, and the other end communicates with the outside of the cup body. The absorbable sealing member is connected to the cup wall to seal the drug release hole.
[0005] As a preferred embodiment, the cup wall includes an integrally formed load-bearing area and a wrapping area, the load-bearing area being vertically opposite to the top of the inner liner, and the drug storage cavity and the drug release hole being disposed in the wrapping area.
[0006] As a preferred embodiment, the outer surface of the cup wall has a wetting layer that covers the drug release hole, and the absorbable sealing element is an absorbable membrane layer attached to the outside of the wetting layer.
[0007] As a preferred embodiment, the absorbable membrane is a polylactic acid-glycolic acid membrane, and the thickness of the polylactic acid-glycolic acid membrane is greater than or equal to 20 micrometers and less than or equal to 50 micrometers.
[0008] As a preferred embodiment, the cup wall has a cup opening and a plurality of threading holes, with each of the threading holes arranged at intervals around the edge of the cup opening.
[0009] As a preferred embodiment, the hemipelvic prosthesis further includes a pubic bone connecting plate, which is detachably connected to the cup wall, and the end of the pubic bone connecting plate away from the cup wall is used to connect to the pubic bone.
[0010] As a preferred embodiment, the hemipelvic prosthesis further includes a first fastener and a second fastener. The first end of the pubic bone connecting plate has a first connecting hole and a second connecting hole. Both the first connecting hole and the second connecting hole are elongated holes, and the length direction of the first connecting hole is perpendicular to the length direction of the second connecting hole. The cup wall has a first threaded hole and a second threaded hole. The first fastener passes through the first connecting hole and is threadedly inserted into the first threaded hole. The second fastener passes through the second connecting hole and is threadedly inserted into the second threaded hole.
[0011] As a preferred embodiment, a first threaded hole and a second threaded hole form a set of pubic bone connection holes, and the cup wall has multiple sets of the pubic bone connection holes, with each set of the pubic bone connection holes arranged at intervals around the axis of the cup body.
[0012] As a preferred embodiment, the hemipelvic prosthesis further includes a sacral connecting plate, which is detachably connected to the cup wall;
[0013] Alternatively, the hemipelvic prosthesis may also include an iliac bone connecting plate, which is detachably connected to the cup wall.
[0014] As a preferred embodiment, the cup body further includes a columnar protrusion, the inner liner mounting cavity is disposed on the inner side of the cup wall, and the columnar protrusion is fixedly connected to the outer side of the cup wall;
[0015] The sacral connecting plate has a first slot, and the columnar protrusion is engaged in the first slot; or, the iliac connecting plate has a second slot, and the columnar protrusion is engaged in the second slot.
[0016] Compared with the prior art, the beneficial effects of this utility model are as follows:
[0017] This utility model discloses a hemipelvic prosthesis, including an acetabular cup. The acetabular cup includes a cup body and an inner liner. The cup body has an inner liner mounting cavity, and at least a portion of the inner liner is disposed in the inner liner mounting cavity. The cup body includes a cup wall for surrounding the inner liner mounting cavity. The cup wall has a drug storage cavity and a drug release hole. One end of the drug release hole communicates with the drug storage cavity, and the other end communicates with the outside of the cup body. After surgery, the acetabular cup also includes an absorbable occluder. The absorbable occluder is connected to the cup wall and seals the drug release hole. Before surgery, an anti-infective drug is added to the drug release hole, and the drug release hole is sealed using the absorbable occluder. After surgery, the absorbable occluder is gradually absorbed, and the drug release hole is opened piece by piece. The anti-infective drug in the drug storage cavity can directly act on the infected site, thereby increasing the concentration of the anti-infective drug at the infected site. Attached Figure Description
[0018] Figure 1 Top view of the acetabular cup;
[0019] Figure 2 Top view of the acetabular cup after concealing the infiltrated layer and absorbable plug;
[0020] Figure 3 for Figure 2 Sectional view along line AA;
[0021] Figure 4 A sectional view along line AA is shown to show the wetting layer and absorbable plug.
[0022] Figure 5 for Figure 4 A magnified view of a section at point C;
[0023] Figure 6 This is an axonometric drawing of the cup.
[0024] Figure 7 Axonometric view of the hemipelvic prosthesis of this invention, after concealing the infiltrative layer and absorbable sealing component;
[0025] Figure 8 Exploded view of the hemipelvic prosthesis of this invention, after concealing the infiltrative layer and absorbable sealing component;
[0026] Figure 9 Axonometric view of the sacral connection plate;
[0027] Figure 10 This is a schematic diagram of the structure of the hemipelvic prosthesis of this utility model when applied to total iliac bone resection surgery;
[0028] Figure 11 This is a schematic diagram of the structure of the hemipelvic prosthesis of this utility model when applied to partial iliac bone resection surgery;
[0029] In the diagram, 1. Acral cup; 11. Cup body; 111. Cup wall; 1111. Drug reservoir; 1112. Drug release hole; 1113. Weight-bearing area; 1114. Enclosure area; 1115. Cup opening; 1116. Threading hole; 1117. First threaded hole; 1118. Second threaded hole; 112. Columnar protrusion; 1121. Limiting groove; 113. Inner liner mounting cavity; 114. Impregnated layer; 12. 13. Absorbable sealing element; 2. Pubic bone connecting plate; 21. Strip plate; 211. Third connecting hole; 22. Arc plate; 221. First connecting hole; 222. Second connecting hole; 31. First fastener; 32. Second fastener; 4. Sacral connecting plate; 41. First slot; 42. First rib; 5. Iliac bone connecting plate; 100. Right pubis; 200. Sacrum; 300. Iliac bone. Detailed Implementation
[0030] The specific embodiments of this utility model will be further described in detail below with reference to the accompanying drawings and examples. The following examples are used to illustrate this utility model, but are not intended to limit the scope of this utility model.
[0031] In the description of this utility model, it should be understood that the terms "upper," "lower," "left," "right," "top," and "bottom," etc., indicating the orientation or positional relationship are based on the orientation or positional relationship shown in the accompanying drawings, and are only for the convenience of describing this utility model and simplifying the description, and do not indicate or imply that the device or element referred to must have a specific orientation, or be constructed and operated in a specific orientation, and therefore should not be construed as a limitation of this utility model. It should be understood that the terms "first," "second," etc., are used in this utility model to describe various information, but this information should not be limited to these terms; these terms are only used to distinguish information of the same type from each other. For example, without departing from the scope of this utility model, "first" information can also be called "second" information, and similarly, "second" information can also be called "first" information.
[0032] like Figures 1 to 11As shown, the hemipelvic prosthesis of this utility model includes an acetabular cup 1, which includes a cup body 11 and an inner liner 12. The cup body 11 has an inner liner mounting cavity 113, and at least a portion of the inner liner 12 is disposed in the inner liner mounting cavity 113. The cup body 11 includes a cup wall 111 for surrounding the inner liner mounting cavity 113. The cup wall 111 has a drug storage cavity 1111 and a drug release hole 1112. One end of the drug release hole 1112 communicates with the drug storage cavity 1111, and the other end communicates with the outside of the cup body 11. The acetabular cup 1 also includes an absorbable sealing member 13, which is connected to the cup wall 111 to seal the drug release hole 1112. Specifically, before surgery, the drug reservoir 1111 is pre-loaded with medication, and the drug release port 1112 is sealed using an absorbable occluder 13 to prevent medication loss during surgery. After surgery, the absorbable occluder 13 degrades naturally in the body fluid environment, allowing the drug release port 1112 to open automatically. The anti-infective drug is liquid and acts directly on the tissues surrounding the acetabular cup 1 through the drug release port 1112. Compared to systemic infusion, this significantly increases the local drug concentration in susceptible areas, making it particularly suitable for patients with weakened immune systems. Compared to infusion, it reduces the hepatotoxicity and nephrotoxicity associated with systemic medication. Furthermore, by integrating the drug reservoir 1111 and the drug release port 1112 into the cup wall 111, there is no need for additional implanted independent drug delivery devices such as infusion tubing or implant pumps, thus avoiding increased surgical trauma and the risk of implant foreign body reactions.
[0033] In this embodiment, the outer surface of the cup wall 111 has an impregnation layer 114, which covers the drug release hole 1112. The absorbable sealing element 13 is an absorbable membrane layer attached to the outside of the impregnation layer 114. Specifically, the impregnation layer 114 covers the drug release hole 1112 and has multiple micropores. The absorbable membrane layer is attached to the outside of the impregnation layer 114. When the absorbable membrane layer degrades, the drug does not directly flow into the surrounding tissue from the release hole, but first enters the micropores of the impregnation layer 114 and then slowly diffuses into the tissue through the micropores. This process can make the release of anti-infective drugs more uniform and the distribution range of anti-infective drugs wider. The degradation of the absorbable membrane layer is the switch for drug release. When the absorbable membrane layer is not degraded, the drug is hardly released; when the absorbable membrane layer begins to degrade, such as when cracks appear on the surface, the drug is released through the cracks and the impregnation layer 114; after the absorbable membrane layer is completely degraded, the impregnation layer 114 is fully exposed, and the drug release rate reaches a stable state. By selecting materials with different degradation rates, it is possible to precisely match the high-risk period for postoperative infection.
[0034] In this embodiment, the absorbable membrane is a polylactic acid-glycolic acid (PLA) membrane with a thickness greater than or equal to 20 micrometers and less than or equal to 50 micrometers. The PLA membrane is copolymerized from lactic acid and glycolic acid, and its degradation products are small-molecule organic acids with no toxic residues. It has been widely used in sutures, drug carriers, and other fields. By adjusting the molecular weight of PLA and the ratio of lactic acid to glycolic acid, the membrane degradation cycle can cover the high-risk period for postoperative infection. If the membrane is too thin, it may be damaged due to pinholes, defects during preparation, or slight friction during surgery, failing to effectively seal the drug release pore 1112 and causing drug loss before or during surgery. A greater thickness results in a longer time required for complete degradation. A thickness of 50 micrometers ensures complete degradation of the membrane within a preset period of approximately 1 to 6 months.
[0035] In this embodiment, as Figure 7 As shown, the cup wall 111 includes an integrally formed load-bearing area 1113 and a wrapping area 1114. The load-bearing area 1113 is vertically opposite to the top of the inner liner 12. The load-bearing area 1113 directly bears the vertical load transmitted by the inner liner 12. The vertical load mainly includes body weight and movement impact force. The load-bearing area 1113 is the core stress area of the acetabular cup 1. Therefore, it is necessary to ensure that the cup wall 111 located in the load-bearing area 1113 has sufficient strength. In this embodiment, the drug storage cavity 1111 and the drug release hole 1112 are set in the wrapping area 1114. The wrapping area 1114 is the other part of the cup wall 111 besides the load-bearing area 1113. The wrapping area 1114 mainly surrounds the side wall of the inner liner 12 and plays the role of wrapping and fixing the inner liner 12. The stress during use is small and the mechanical strength requirement is lower than that of the load-bearing area 1113. Therefore, functional structures such as the drug storage cavity 1111 and the drug release hole 1112 can be set without affecting the overall load-bearing capacity of the acetabular cup 1.
[0036] In this embodiment, the cup body 11 is made of a biocompatible metal material and is manufactured using 3D printing. The cup wall 111 contains multiple drug storage chambers 1111, each forming a honeycomb structure. The volume of each drug storage chamber 1111 is approximately 1 cubic millimeter. Each chamber 1111 holds 10 to 20 microliters of anti-infective drug. The pore size of the drug release orifice 1112 is approximately 0.5 mm. The pore size of the infiltration layer 114 on the outer surface of the cup body 11 is 50 to 200 micrometers. The infiltration layer 114 can be formed by 3D printing or by laser fusion. In this embodiment, the infiltration layer 114 is the same as the osteointegration layer on the outer surface of the prosthesis in the prior art.
[0037] In this embodiment, the cup wall 111 has a cup opening 1115 and multiple suture holes 1116, with each suture hole 1116 spaced around the edge of the cup opening 1115. Specifically, after pelvic tumor resection, the patient's affected hip joint capsule tissue will be lost to varying degrees, causing damage to the hip joint capsule. If the wound is directly sutured, the femoral head may easily slip out of the acetabular cup 1 due to insufficient surrounding protection. Therefore, in order to keep the femoral head in a relatively closed capsule after the prosthesis is installed and reduced, in this embodiment, suture holes 1116 are provided at the edge of the cup wall 111. Sutures are used to pass through the suture holes 1116 on one side and through the surrounding tissues such as the origin and insertion points of the rectus femoris muscle, the remaining pectineus muscle, psoas major muscle, piriformis muscle, quadratus femoris muscle, adductor longus muscle, obturator internus muscle, etc., along the edge of the cup opening 1115 for circumferential fixation, so that the entire proximal femur is covered and wrapped by muscle and soft tissue, thereby achieving the purpose of reconstructing the hip joint capsule. This can reduce the postoperative femoral head dislocation rate.
[0038] In this embodiment, the hemipelvic prosthesis also includes a pubic bone connecting plate 2, which is detachably connected to the cup wall 111. The end of the pubic bone connecting plate 2 away from the cup wall 111 is used to connect to the pubic bone. Specifically, the pubic bone is an important component of the human pelvis, located below the lower abdomen, with one on each side connected by cartilage, i.e., the pubic symphysis. For patients requiring removal of the left pubic bone, the discontinuity of the anterior pelvic ring is interrupted after the left pubic bone is removed, leading to decreased pelvic ring stability, postoperative pelvic tilt, limb shortening, and ineffective transmission of trunk strength to the lower limbs, affecting walking function. Figure 10 , Figure 11 As shown, a pubic connecting plate 2 is connected to the lower part of the cup wall 111. The end of the pubic connecting plate 2 away from the cup wall 111 is connected to the right pubic bone 100. The pubic connecting plate 2 replaces the missing left pubic bone portion, reconstructing the mechanical continuity of the anterior pelvic ring. Moreover, the pubic connecting plate 2 and the cup wall 111 are detachably connected, rather than being integrally molded. The detachable design allows the surgeon to select connecting plates of different lengths and angles according to the actual situation during surgery, avoiding poor fit caused by fixed dimensions. This makes the hemipelvic prosthesis of this embodiment more suitable for the anatomical differences of different patients. In addition, the hemipelvic prosthesis implantation surgery is complex, requiring the acetabular cup 1 to be fixed first, and then the position of the pubic connecting plate 2 to match the remaining pubic bone. The detachable design allows the surgeon to fix the acetabular cup 1 first, and then install the connecting plate, reducing the difficulty of the surgery and reducing soft tissue traction damage during surgery.
[0039] In this embodiment, as Figure 7 , Figure 8As shown, the hemipelvic prosthesis also includes a first fastener 31 and a second fastener 32. The first end of the pubic connecting plate 2 has a first connecting hole 221 and a second connecting hole 222. Both the first connecting hole 221 and the second connecting hole 222 are elongated holes, and the length direction of the first connecting hole 221 is perpendicular to the length direction of the second connecting hole 222. The cup wall 111 has a first threaded hole 1117 and a second threaded hole 1118. The first fastener 31 passes through the first connecting hole 221 and is threadedly inserted into the first threaded hole 1117. The second fastener 32 passes through the second connecting hole 222 and is threadedly inserted into the second threaded hole 1118. Specifically, in hemipelvic replacement surgery, reconstruction of the pubic region is one of the difficulties because the anatomical structure of the pubic region is complex and adjacent to important tissues such as the bladder and blood vessels. In this embodiment, when connecting the pubic connecting plate 2 to the cup wall 111, it can be finely adjusted along the first and second directions to facilitate the connection of the pubic connecting plate 2 to the cup wall 111. Specifically, in this embodiment, the pubic bone connecting plate 2 includes a strip plate 21 and an arc plate 22. The arc plate 22 and the strip plate 21 are arranged perpendicularly or at an angle. The arc plate 22 matches the outer surface of the cup wall 111. The first connecting hole 221 and the second connecting hole 222 are provided on the arc plate 22. The end of the strip plate 21 away from the arc plate 22 is provided with a third connecting hole 211 for connecting the pubic bone.
[0040] Furthermore, in this embodiment, a first threaded hole 1117 and a second threaded hole 1118 form a set of pubic bone connection holes. The cup wall 111 has multiple sets of pubic bone connection holes, and each set of pubic bone connection holes is arranged at intervals around the axis of the cup body 11. Specifically, the abduction angle and anteversion angle of the acetabular cup 1 are the core parameters that determine the postoperative stability and range of motion of the hip joint: too large or too small an angle may lead to hip dislocation or impingement syndrome; during the operation, the acetabular cup 1 needs to be rotated and adjusted in real time according to the patient's pelvic anatomy, such as the development of the acetabulum and the amount of residual bone, to obtain the optimal angle. However, rotational adjustment will cause the positions of the first threaded hole 1117 and the second threaded hole 1118 on the cup wall 111 to rotate accordingly. If only one set of connecting holes is provided, the first connecting hole 221 and the second connecting hole 222 may not be able to match and fix with the pubic connecting plate 2. In this embodiment, multiple sets of pubic connecting holes are provided, so they can adapt to the acetabular cup 1 from different angles, so that the acetabular cup 1 can still have a suitable pubic connecting hole at the position near the midline of the pelvis after rotational adjustment, thereby enabling the pubic connecting plate 2 to be connected to the cup wall 111.
[0041] In this embodiment, one of the first threaded hole 1117 and the second threaded hole 1118 can be set close to the cup opening 1115. For example, if the first threaded hole 1117 is set close to the cup opening, the first threaded hole 1117 and the wire hole 1116 can be arranged alternately along the circumference of the cup body 11. The first threaded hole 1117 without the first fastener 31 installed can be used to thread the wire.
[0042] In this embodiment, the hemipelvic prosthesis also includes a sacral connecting plate 4, such as Figures 7 to 10 As shown, the sacral connecting plate 4 is detachably connected to the cup wall 111; alternatively, the hemipelvic prosthesis also includes an iliac connecting plate 5, which is detachably connected to the cup wall 111. Specifically, the sacrum 200 connects the spine and the iliac bone 300 and is the core structure of the posterior pelvic ring. If the iliac bone 300 is completely removed during surgery, it is necessary to connect the acetabular cup 1 to the sacrum 200 to reconstruct the posterior pelvic ring force chain. The sacral connecting plate 4 serves to connect the cup wall 111 to the sacrum 200 and reconstruct the posterior pelvic ring force chain. Detachably connecting the sacral connecting plate 4 to the cup wall 111 facilitates the selection of a suitable sacral connecting plate 4 based on the patient's condition. If the iliac bone 300 is not completely removed but partially removed, it is necessary to connect the cup wall 111 to the remaining iliac bone 300. In this embodiment, the iliac connecting plate 5 can connect the cup wall 111 to the remaining iliac bone 300 when the iliac bone 300 is partially removed. That is, in the same operation, depending on the iliac bone 300 resection, either sacral connecting plate 4 or sacral connecting plate 4 can be selected.
[0043] In this embodiment, the cup body 11 further includes a columnar protrusion 112, the inner lining mounting cavity 113 is disposed on the inner side of the cup wall 111, and the columnar protrusion 112 is fixedly connected to the outer side of the cup wall 111; the sacral connecting plate 4 has a first slot 41, and the columnar protrusion 112 is engaged in the first slot 41; or, the iliac connecting plate 5 has a second slot, and the columnar protrusion 112 is engaged in the second slot. Specifically, the protruding column and slot structure enables quick and convenient connection between the cup wall 111 and the sacral connecting plate 4. The outer periphery of the columnar protrusion 112 is provided with multiple evenly spaced limiting grooves 1121, the length direction of each groove being parallel to the circumferential direction of the columnar protrusion 112. The inner wall of the first slot 41 is fixed with multiple first ribs 42. After the columnar protrusion 112 is inserted into the first slot 41, each first rib 42 is respectively engaged in the corresponding limiting groove 1121. The inner wall of the second slot is fixed with multiple second ribs. After the columnar protrusion 112 is inserted into the second slot, each second rib is respectively engaged in the corresponding limiting groove 1121. In this embodiment, the columnar protrusion 112 is connected to the load-bearing area.
[0044] In summary, the hemipelvic prosthesis of this utility model includes an acetabular cup 1, which comprises a cup body 11 and an inner liner 12. The cup body 11 has an inner liner mounting cavity 113, and at least a portion of the inner liner 12 is disposed within the inner liner mounting cavity 113. The cup body 11 includes a cup wall 111 for surrounding the inner liner mounting cavity 113. The cup wall 111 has a drug storage cavity 1111 and a drug release hole 1112. One end of the drug release hole 1112 communicates with the drug storage cavity 1111, and the other end communicates with the outside. After surgery, the acetabulum... The cup 1 also includes an absorbable sealing element 13, which is connected to the cup wall 111 and seals the drug release hole 1112. Before the operation, the anti-infective drug is added to the drug release hole 1112 and the absorbable sealing element 13 is used to seal the drug release hole 1112. After the operation, the absorbable sealing element 13 is gradually absorbed, and the drug release port is opened one by one. The anti-infective drug in the drug storage chamber 1111 can directly act on the infected site, thereby increasing the concentration of anti-infective drug at the infected site.
[0045] The above description is only a preferred embodiment of the present utility model. It should be noted that for those skilled in the art, several improvements and substitutions can be made without departing from the technical principles of the present utility model, and these improvements and substitutions should also be considered within the protection scope of the present utility model.
Claims
1. A hemi-pelvis prosthesis, characterized in that, The device includes an acetabular cup (1), which includes a cup body (11), a liner (12), and an absorbable occluder (13). The cup body (11) has a liner mounting cavity (113), at least a portion of which is disposed in the liner mounting cavity (113). The cup body (11) includes a cup wall (111) for surrounding the liner mounting cavity (113), the cup wall (111) having a drug reservoir (1111) and a drug release hole (1112), one end of which communicates with the drug reservoir (1111) and the other end of which communicates with the outside of the cup body (11). The absorbable occluder (13) is connected to the cup wall (111) to block the drug release hole (1112).
2. The hemipelvic prosthesis according to claim 1, characterized in that, The cup wall (111) includes an integrally formed load-bearing area (1113) and a wrapping area (1114). The load-bearing area (1113) is vertically opposite to the top of the inner liner (12). The drug storage cavity (1111) and the drug release hole (1112) are located in the wrapping area (1114).
3. The hemipelvic prosthesis according to claim 1, characterized in that, The outer surface of the cup wall (111) has an impregnation layer (114) that covers the drug release hole (1112). The absorbable sealing member (13) is an absorbable membrane layer attached to the outside of the impregnation layer (114).
4. The hemipelvic prosthesis according to claim 3, characterized in that, The absorbable membrane is a polylactic acid-glycolic acid membrane, and the thickness of the polylactic acid-glycolic acid membrane is greater than or equal to 20 micrometers and less than or equal to 50 micrometers.
5. The hemipelvic prosthesis according to claim 1, characterized in that, The cup wall (111) has a cup mouth (1115) and a plurality of thread holes (1116), each of the thread holes (1116) being arranged at intervals around the edge of the cup mouth (1115).
6. The hemipelvic prosthesis according to claim 1, characterized in that, The hemipelvic prosthesis also includes a pubic bone connecting plate (2), which is detachably connected to the cup wall (111). The end of the pubic bone connecting plate (2) away from the cup wall (111) is used to connect to the pubic bone.
7. The hemipelvic prosthesis according to claim 6, characterized in that, The hemipelvic prosthesis also includes a first fastener (31) and a second fastener (32). The first end of the pubic bone connecting plate (2) has a first connecting hole (221) and a second connecting hole (222). Both the first connecting hole (221) and the second connecting hole (222) are elongated holes. The length direction of the first connecting hole (221) is perpendicular to the length direction of the second connecting hole (222). The cup wall (111) has a first threaded hole (1117) and a second threaded hole (1118). The first fastener (31) passes through the first connecting hole (221) and is threadedly inserted into the first threaded hole (1117). The second fastener (32) passes through the second connecting hole (222) and is threadedly inserted into the second threaded hole (1118).
8. The hemipelvic prosthesis according to claim 7, characterized in that, A first threaded hole (1117) and a second threaded hole (1118) form a set of pubic bone connection holes. The cup wall (111) has multiple sets of the pubic bone connection holes, and each set of the pubic bone connection holes is arranged at intervals around the axis of the cup body (11).
9. The hemipelvic prosthesis according to claim 1, characterized in that, The hemipelvic prosthesis also includes a sacral connecting plate (4), which is detachably connected to the cup wall (111); Alternatively, the hemipelvic prosthesis may also include an iliac bone connecting plate (5), which is detachably connected to the cup wall (111).
10. The hemipelvic prosthesis according to claim 9, characterized in that, The cup body (11) also includes a columnar protrusion (112), the inner liner mounting cavity (113) is disposed on the inner side of the cup wall (111), and the columnar protrusion (112) is fixedly connected to the outer side of the cup wall (111); The sacral connecting plate (4) has a first slot (41), and the columnar protrusion (112) is engaged in the first slot (41); or, the iliac connecting plate (5) has a second slot, and the columnar protrusion (112) is engaged in the second slot.
